The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical stages in the U.S. and China. Concurrently, the ...
Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...
Two recent studies conducted by scientists at the University Health Network and the University of Toronto provide new ...
Abstract: Proper maintenance of Induction Machines (IM) is essential to ensure suitable performance, extend their service lifespan, and minimize the risk of catastrophic failures. Bearing failures are ...
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors. In this manuscript, ...
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...
Q.ANT's new chip uses photon power in a bid to solve AI's big energy issue. It's also 50 times faster than silicon-based equivalents, the company says. When you purchase through links on our site, we ...
Aicardi-Goutières syndrome (AGS) is a rare genetic disorder classified among type I interferonopathies. Current pharmacological management of AGS is symptomatic and supportive, with recent clinical ...
Abstract: In order to improve the computational efficiency and accuracy of the nonlinear inversion of horizontal well array induction logging, the neural network is introduced into the inversion of ...
α-Synuclein (αSyn) is a small, disordered protein that becomes aggregated in Lewy body diseases, such as Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Human induced pluripotent stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results